The New Zealand Government has granted Covid-19 vaccine suppliers, Pfizer and BioNTech, indemnity from any claims that may arise from use of the vaccine, RNZ reports. Pharmaceutical companies often seek indemnities when developing a pandemic vaccine, because of the need to speed up the clinical trial process. Indemnities may also be granted to the other suppliers of Covid-19 vaccines that New Zealand has secured. Pfizer and BioNTech are supplying 750,000 courses of their Covid-19 vaccine.
Recent Comments